Form 8-K - Current report:
SEC Accession No. 0000950170-25-064432
Filing Date
2025-05-06
Accepted
2025-05-06 16:05:10
Documents
13
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20250506.htm   iXBRL 8-K 41611
2 EX-99.1 cytk-ex99_1.htm EX-99.1 240991
3 GRAPHIC img114956760_0.jpg GRAPHIC 23462
  Complete submission text file 0000950170-25-064432.txt   446869

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20250506.xsd EX-101.SCH 25033
15 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20250506_htm.xml XML 4753
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 25917176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)